These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20461887)

  • 1. Heat-labile enterotoxins as adjuvants or anti-inflammatory agents.
    Liang S; Hajishengallis G
    Immunol Invest; 2010; 39(4-5):449-67. PubMed ID: 20461887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II heat-labile enterotoxins: structure, function, and immunomodulatory properties.
    Hajishengallis G; Connell TD
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):68-77. PubMed ID: 23137790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.
    Connell TD
    Expert Rev Vaccines; 2007 Oct; 6(5):821-34. PubMed ID: 17931161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and structural characterization of the novel sialic acid-binding site of Escherichia coli heat-labile enterotoxin LT-IIb.
    Zalem D; Ribeiro JP; Varrot A; Lebens M; Imberty A; Teneberg S
    Biochem J; 2016 Nov; 473(21):3923-3936. PubMed ID: 27562297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Mucosal Adjuvant Activities of ADP-Ribosylating Bacterial Enterotoxins.
    Snider DP
    Crit Rev Immunol; 2017; 37(2-6):499-530. PubMed ID: 29773032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological similarity of enterotoxins of Vibrio cholerae serotypes other than type 1 to cholera toxin and Escherichia coli heat-labile enterotoxin.
    Lahiri A; Agarwal RK; Sanyal SC
    J Med Microbiol; 1982 Nov; 15(4):429-40. PubMed ID: 6757437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine.
    Tamura SI; Kurata T
    Jpn J Infect Dis; 2000 Jun; 53(3):98-106. PubMed ID: 10957706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses.
    Bagley K; Xu R; Ota-Setlik A; Egan M; Schwartz J; Fouts T
    Hum Vaccin Immunother; 2015; 11(9):2228-40. PubMed ID: 26042527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of heat-labile enterotoxins type IIa and type IIb in the pathogenicity of enterotoxigenic Escherichia coli for neonatal pigs.
    Casey TA; Connell TD; Holmes RK; Whipp SC
    Vet Microbiol; 2012 Sep; 159(1-2):83-9. PubMed ID: 22480773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid.
    Holmgren J
    Infect Immun; 1973 Dec; 8(6):851-9. PubMed ID: 4206342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholera toxin and related enterotoxins: a cell biological and immunological perspective.
    de Haan L; Hirst TR
    J Nat Toxins; 2000 Aug; 9(3):281-97. PubMed ID: 10994530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with a Double-Mutant (R192G/L211A) of the Heat-Labile Enterotoxin of Escherichia coli Offers Partial Protection against Campylobacter jejuni in an Adult Mouse Intestinal Colonization Model.
    Albert MJ; Haridas S; Ebenezer M; Raghupathy R; Khan I
    PLoS One; 2015; 10(11):e0142090. PubMed ID: 26540197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria.
    Klipstein FA; Engert RF
    Infect Immun; 1977 Oct; 18(1):110-7. PubMed ID: 332637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections.
    Hajishengallis G; Arce S; Gockel CM; Connell TD; Russell MW
    J Dent Res; 2005 Dec; 84(12):1104-16. PubMed ID: 16304439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of live attenuated bacterial vaccines targeting Escherichia coli heat-labile and heat-stable enterotoxins.
    Zhu C; Setty P; Boedeker EC
    Vet Microbiol; 2017 Apr; 202():72-78. PubMed ID: 28527491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gangliosides inhibit serological reactions for the detection of cholera and heat-labile enterotoxins of Escherichia coli.
    Ricci LC; de-Siqueira PS; Castro AF
    Braz J Med Biol Res; 1992; 25(8):805-7. PubMed ID: 1342612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins.
    Mourad FH; O'Donnell LJ; Dias JA; Ogutu E; Andre EA; Turvill JL; Farthing MJ
    Gut; 1995 Sep; 37(3):340-5. PubMed ID: 7590428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory regulation by heat-labile enterotoxins and potential therapeutic applications.
    Knapp MA; Johnson TA; Ritter MK; Rainer RO; Fiester SE; Grier JT; Connell TD; Arce S
    Expert Rev Vaccines; 2021 Aug; 20(8):975-987. PubMed ID: 34148503
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines.
    Sunagar R; Singh A; Kumar S
    Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges.
    Chen CH; Chen CC; Wang WB; Lionel V; Liu CC; Huang LM; Wu SC
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.